Dopaminergic basis of salience dysregulation in psychosis.
about
Emotionally Neutral Stimuli Are Not Neutral in Schizophrenia: A Mini Review of Functional Neuroimaging StudiesMultiple D2 heteroreceptor complexes: new targets for treatment of schizophreniaHippocampal-Prefrontal Interactions in Cognition, Behavior and Psychiatric DiseaseDiametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunologyAn Overview of the Association between Schizotypy and Dopamine.Computational Psychiatry: towards a mathematically informed understanding of mental illnessAberrant Salience Is Related to Dysfunctional Self-Referential Processing in Psychosis.Corticolimbic dysfunction during facial and prosodic emotional recognition in first-episode psychosis patients and individuals at ultra-high risk.Sensorimotor gating, cannabis use and the risk of psychosisTest-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging.Phasic dopamine release in the rat nucleus accumbens predicts approach and avoidance performance.The effects of cannabis use on salience attribution: a systematic review.The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatmentStructural Network Disorganization in Subjects at Clinical High Risk for Psychosis.An Integrative Perspective on the Role of Dopamine in SchizophreniaVTA dopaminergic neurons regulate ethologically relevant sleep-wake behaviors.Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.Levodopa administration modulates striatal processing of punishment-associated items in healthy participants.Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies.Impaired effort allocation in patients with schizophrenia.Diagnostic classification of schizophrenia patients on the basis of regional reward-related FMRI signal patterns.Focus on psychosis.Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and DiseaseStress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling StudyGlutamate and dopamine in schizophrenia: an update for the 21st centuryDeficits in context-dependent adaptive coding of reward in schizophrenia.The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity.Altered Insular Function during Aberrant Salience Processing in Relation to the Severity of Psychotic Symptoms.Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.The neurobiology and treatment of first-episode schizophrenia.What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit.Schizophrenia in 2020: Trends in diagnosis and therapy.A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.Decoding emotion of the other differs among schizophrenia patients and schizoaffective patients: A pilot study.Using Intermediate Cognitive Endpoints to Facilitate Translational Research in Psychosis.Limbic Interference During Social Action Planning in Schizophrenia.Reward Processing, Neuroeconomics, and Psychopathology.Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.Deictic and Propositional Meaning-New Perspectives on Language in Schizophrenia.
P2860
Q26738286-5A8AF697-142F-4425-B16F-F5B9A85724D1Q26747736-15E09B1B-48A6-40B5-8422-1FB5B5CCDAC0Q26767711-D17C0002-F85D-4258-8538-F712F8286329Q26782139-235B03F9-A5FD-452F-96E4-8D76A9F30771Q26991569-B80913CB-54FC-4CD9-980C-3C2A9CA8A914Q28081014-9EFE63B2-0C7E-46DE-A5C0-6234D7E23891Q30367037-490517BD-C3AE-451B-BF8D-37998944ABD6Q30372428-01EBE1B7-BC7F-43DF-A5E8-87919911F44EQ30411076-CFF4BE98-948F-41E6-AED9-4AA9D9F43897Q30572286-8C825316-A944-4D3D-9A2A-9F23A684251FQ30827467-2BA5659D-15ED-4CC0-AC13-94D7311F2D70Q31143453-F4E4CE1B-01C9-4D7B-AD2F-DC83AFBB4B68Q33593061-53F4A9C0-41B8-4F63-8140-63C5AEEB46D5Q33777660-BA321280-AC3C-4A4E-B27C-C1815A4C6BB4Q33839379-9A3B5AB4-05C4-47A4-A53C-755EF2D0CDB0Q33921371-A61FFECC-9E7E-43E9-B37D-46107039AA5BQ34410670-2AE7CEA3-131B-4CBE-AD0B-AACD75ABB950Q34694053-A7F15A70-81E4-4D3F-B024-08B7F1A4C696Q34765148-8615DBF4-53C1-437B-8386-A5C4D4E6F9BDQ35020008-F6573488-C913-4D4C-9286-54A3027F0004Q35208480-FE7A5BE3-8236-4A69-8388-25ADFD967E13Q35575042-0922CDB8-8257-4EA5-BA33-D76ACD7D11E9Q36300230-66967508-B724-4982-AEBB-E2A7CD17B9C4Q36817265-C3232DDF-62D6-4A9B-A183-F512F141C4CEQ36992322-8F6910A0-36CF-46EE-94D8-1D7B000B4983Q37095155-99A3338F-4B32-4357-9334-F68BF976C57EQ37198435-DC8681FC-2231-4C2B-8392-CA9C5F0B1868Q37430456-B205FA13-1945-461D-B136-F2F2E211E1D2Q37563725-4B13DAAD-BBC6-412A-B7F2-2CA6056E8ADFQ38232366-27CDA77B-8663-428A-B76C-F854686DC54AQ38249908-E417606D-BCB0-4927-8A1C-C14D6C80BF49Q38502779-57CE4C0C-25AC-460F-AAF7-24EDA1275DF1Q38593718-0A1B2FFE-2A9F-4E44-922E-07319C171B3CQ38650161-2D95A7F7-E268-4F33-81A0-2C4B78BF110FQ38663236-7C4528D9-EDA7-4A8B-916B-5F1C7B30DBD9Q38670526-C8DD2B6F-9428-4292-B511-284AD99657A0Q38748222-9B66641A-86CD-4495-AEE7-7AF4F0641B7AQ38903075-2D45003F-EA50-4604-8D29-030B490FA144Q38915253-F2833C62-8692-4A1D-BA9E-7A0A8C48DB07Q39151949-1C9DFF01-56C8-46A6-8733-5E282D9B14E0
P2860
Dopaminergic basis of salience dysregulation in psychosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dopaminergic basis of salience dysregulation in psychosis.
@en
type
label
Dopaminergic basis of salience dysregulation in psychosis.
@en
prefLabel
Dopaminergic basis of salience dysregulation in psychosis.
@en
P50
P1476
Dopaminergic basis of salience dysregulation in psychosis.
@en
P2093
Toby T Winton-Brown
P356
10.1016/J.TINS.2013.11.003
P577
2014-01-02T00:00:00Z